AMANDA HAMMONS: Open Payments
NPI 1033546296 · CORBIN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$388 in 21 payments from 11 companies in 2025. Trend: 2023 $422 · 2024 $599 · 2025 $388
Food & beverage: $388
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 10 | $184 |
| Lilly USA, LLC | 2 | $30 |
| BETA BIONICS, INC. | 1 | $28 |
| Axsome Therapeutics, Inc. | 1 | $21 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $20 |
| ABBVIE INC. | 1 | $19 |
| Novo Nordisk Inc | 1 | $18 |
| Astellas Pharma US Inc | 1 | $18 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $15 |
Products named: ELIQUIS, MOUNJARO, iLet Bionic Pancreas, Auvelity, Kerendia, VERQUVO, VRAYLAR, Wegovy.
Industry payments across KY — which companies pay providers there.
